Cargando…
Kinesin family member 2A acts as a potential prognostic marker and treatment target via interaction with PI3K/AKT and RhoA/ROCK pathways in acute myeloid leukemia
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813551/ https://www.ncbi.nlm.nih.gov/pubmed/36524357 http://dx.doi.org/10.3892/or.2022.8463 |
_version_ | 1784863947297390592 |
---|---|
author | Liang, Xinglin Xia, Ruixiang |
author_facet | Liang, Xinglin Xia, Ruixiang |
author_sort | Liang, Xinglin |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9813551 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-98135512023-01-12 Kinesin family member 2A acts as a potential prognostic marker and treatment target via interaction with PI3K/AKT and RhoA/ROCK pathways in acute myeloid leukemia Liang, Xinglin Xia, Ruixiang Oncol Rep Corrigendum D.A. Spandidos 2022-12-13 /pmc/articles/PMC9813551/ /pubmed/36524357 http://dx.doi.org/10.3892/or.2022.8463 Text en Copyright: © Liang et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited. |
spellingShingle | Corrigendum Liang, Xinglin Xia, Ruixiang Kinesin family member 2A acts as a potential prognostic marker and treatment target via interaction with PI3K/AKT and RhoA/ROCK pathways in acute myeloid leukemia |
title | Kinesin family member 2A acts as a potential prognostic marker and treatment target via interaction with PI3K/AKT and RhoA/ROCK pathways in acute myeloid leukemia |
title_full | Kinesin family member 2A acts as a potential prognostic marker and treatment target via interaction with PI3K/AKT and RhoA/ROCK pathways in acute myeloid leukemia |
title_fullStr | Kinesin family member 2A acts as a potential prognostic marker and treatment target via interaction with PI3K/AKT and RhoA/ROCK pathways in acute myeloid leukemia |
title_full_unstemmed | Kinesin family member 2A acts as a potential prognostic marker and treatment target via interaction with PI3K/AKT and RhoA/ROCK pathways in acute myeloid leukemia |
title_short | Kinesin family member 2A acts as a potential prognostic marker and treatment target via interaction with PI3K/AKT and RhoA/ROCK pathways in acute myeloid leukemia |
title_sort | kinesin family member 2a acts as a potential prognostic marker and treatment target via interaction with pi3k/akt and rhoa/rock pathways in acute myeloid leukemia |
topic | Corrigendum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813551/ https://www.ncbi.nlm.nih.gov/pubmed/36524357 http://dx.doi.org/10.3892/or.2022.8463 |
work_keys_str_mv | AT liangxinglin kinesinfamilymember2aactsasapotentialprognosticmarkerandtreatmenttargetviainteractionwithpi3kaktandrhoarockpathwaysinacutemyeloidleukemia AT xiaruixiang kinesinfamilymember2aactsasapotentialprognosticmarkerandtreatmenttargetviainteractionwithpi3kaktandrhoarockpathwaysinacutemyeloidleukemia |